LocationLocation:
Chelsea (London)
DepartmentDepartment:
Cancer and Genome Instability
Contract:Contract:
Fixed term
External Advertising End Date
23 Sep 2024

Key Information

Salary: £58,398.00 - The appointment will be on Fixed Term Contract for three years. This fellowship position will be registered to study for a PhD qualification under the supervision of Professor Wojciech Niedzwiedz and Professor Richard Houlston.
 
Please note this is a rolling advert with no specific closing date, which will close once the position is filled. Applications will be considered as they arrive.
 
Pay award pending.
 
 
 

Job Details

 
We are seeking  to appoint a Clinical Research Fellow to undertake a fully funded translational PhD project entitled: 
 
Decoding the Cancer Genome to inform patient care: Identifying DNA damage response biomarkers and novel synthetic lethal targets.
 
The objective is to to utilise whole genome sequencing data from patient tumours to map tumour-type or cohort-specific DNA Damage Response (DDR) activity in order to advance precision oncology by identifying: 1) DNA repair factors driving specific mutational patterns; 2) novel synthetic lethal targets paired with actionable biomarkers.

Key Requirements

Candidates must have full GMC Registration, an MB BS degree (or equivalent), and a keen interest in decoding cancer genome through advanced genomic insights.

Divisions of Cancer Biology and Genetics and Epidemiology

Professor Wojciech Niedzwiedz investigates the mechanisms by which cells detect and repair damaged DNA, and how dysregulation of DNA damage responses leads to genomic instability, cancer-prone and premature aging syndromes. Professor Niedzwiedz heads the Cancer and Genome Instability Group within the Division of Cancer Biology.

Professor Richard Houlston is Head of the Division of Genetics and Epidemiology. His research focuses on the identification and characterisation of genetic susceptibility to cancer.
 
We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Professor Wojciech Niedzwiedz at [email protected].

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

 

We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.


Other jobs like this

Location
Chelsea (London)
Department
Cancer and Genome Instability
Contract:
Fixed term
External Advertising End Date
23 Sep 2024
Location
Chelsea (London)
Department
Post-translational modifications and cell proliferation
Salary Details:
Salary range £35,844 - £42,372
Contract:
Fixed term
External Advertising End Date
18 Aug 2024
Location
Sutton (Greater London)
Department
Breast Cancer
Salary Details:
£28,500 - £30,000
Contract:
Fixed term
External Advertising End Date
07 Aug 2024